בטאקורטן קרם ישראל - עברית - Ministry of Health

בטאקורטן קרם

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate - קרם - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions.

בטאקורטן משחה ישראל - עברית - Ministry of Health

בטאקורטן משחה

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate - משחה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions.

בטאקורטן G משחה ישראל - עברית - Ministry of Health

בטאקורטן g משחה

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - משחה - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

בטאקורטן G קרם ישראל - עברית - Ministry of Health

בטאקורטן g קרם

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - קרם - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone and antibiotics - betamethasone and antibiotics - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

דיפרוספאן זריקה ישראל - עברית - Ministry of Health

דיפרוספאן זריקה

organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.

פרוטופיק % 0.03 ישראל - עברית - Ministry of Health

פרוטופיק % 0.03

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.03 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

פרוטופיק % 0.1 ישראל - עברית - Ministry of Health

פרוטופיק % 0.1

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.1 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).